Annapolis Financial Services’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-25
Closed -$5K 459
2022
Q3
$5K Buy
+25
New +$5.4K ﹤0.01% 390

Other funds holding CRL

Annapolis Financial Services's CRL Position: Q4 2022 in Review

Annapolis Financial Services sold out of Charles River Laboratories (CRL) in Q4 2022, closing a stake of 25 shares — an estimated $5K sold.

Annapolis Financial Services first reported a position in CRL in Q3 2022 and held it in 1 quarter. The position peaked at $5K in Q3 2022. 627 funds tracked by Wall St. Rank hold CRL as of Q4 2022.

  • Annapolis Financial Services reported no remaining Charles River Laboratories position as of Q4 2022 after selling out during the quarter.
  • Annapolis Financial Services sold 25 Charles River Laboratories shares in Q4 2022, an estimated $5K.
  • Annapolis Financial Services first reported a position in Charles River Laboratories in Q3 2022 and held it in 1 quarter.
  • Annapolis Financial Services's Charles River Laboratories position peaked at $5K in Q3 2022.
  • 627 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2022.

Based on Annapolis Financial Services's 13F filing for Q4 2022, filed 23 Jan 2023.